ZN-c3

CAS No. 2376146-48-2

ZN-c3( —— )

Catalog No. M28820 CAS No. 2376146-48-2

ZN-c3 is a potent and selective Wee1 inhibitor with balanced potency, ADME, and pharmacokinetic properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 263 In Stock
5MG 227 In Stock
10MG 353 In Stock
25MG 655 In Stock
50MG 1014 In Stock
100MG 1516 In Stock
200MG 2037 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ZN-c3
  • Note
    Research use only, not for human use.
  • Brief Description
    ZN-c3 is a potent and selective Wee1 inhibitor with balanced potency, ADME, and pharmacokinetic properties.
  • Description
    ZN-c3 is a potent and selective Wee1 inhibitor with balanced potency, ADME, and pharmacokinetic properties.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Wee1
  • Recptor
    tau
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2376146-48-2
  • Formula Weight
    526.63
  • Molecular Formula
    C29H34N8O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C=C)N1N(C=2C(C1=O)=CN=C(NC3=CC=C(C=C3)N4CCN(C)CC4)N2)C=5N=C6C(=CC5)CC[C@@]6(CC)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.REMYND; KATHOLIEKE UNIVERSITEIT LEUVEN - WO2012/80220, 2012, A1
molnova catalog
related products
  • Adavosertib

    A potent and selective small-molecule inhibitor of Wee1 kinase with IC50 of 5.2 nM.

  • RP-6306

    Lunresertib (RP-6306) is a potent, selective, and orally active PKMYT1 inhibitor with an IC50 of 14 nM. Lunresertib (RP-6306) inhibits the growth of CCNE1-amplified tumor cells in several preclinical xenograft models.

  • Debio-0123

    Debio-0123 (WEE1-IN-5) is a potent, orally available and highly specific WEE1 inhibitor with an IC 50 in the low nanomolar range.